Ketotrexate

InformationKDM4D-IN-1 KDM4D-IN-1 is a potent inhibitor of KDM4D with an IC50 of 0.41 μM.TargetsKDM4D (Cell-free assay) 0.41 μM.

InformationKDM4D-IN-1 KDM4D-IN-1 is a potent inhibitor of KDM4D with an IC50 of 0.41 μM.TargetsKDM4D (Cell-free assay) 0.41 μM.

KDOAM-25 is a potent and highly selective histone lysine demethylases 5 (KDM5) inhibitor with IC 50 s of 71 nM, 19 nM, 69 nM, 69 nM for KDM5A, KDM5B, KDM5C, KDM5D, respectively. KDOAM-25 increases global H3K4 methylation at transcriptional start

Keliximab (anti-CD4) with a Ki value of 1.0 nM for soluble CD4.

Keliximab (anti-CD4) with a Ki value of 1.0 nM for soluble CD4.

Keliximab (anti-CD4) with a Ki value of 1.0 nM for soluble CD4.

Keliximab (anti-CD4) with a Ki value of 1.0 nM for soluble CD4.

Synonym(s): Bicyclohexane-4,4'-dione monoethylene ketal Formula: C14H22O3 Formula weight: 238.33 Purity: 97% CAS Number: 56309-94-5 <stro

Biochem/physiol Actions Kevetrin is an activator/stabilizer of wild type p53 tumor suppressor protein in human lung carcinoma and ovarian cancer cells that induces cell cycle arrest and apoptosis. Additionally Kevetrin down-regulates oncogenic

A potent synthetic &alpha-galactosylceramide, which, in association with the antigen-presenting CD1d protein, activates NKT immune cells has activity in many diseases, including cancer, lupus, diabetes, malaria, and tuberculosis.

Legal Information Krytox is a registered trademark of E. I.

Legal Information Krytox is a registered trademark of E. I.